Monday March 16, 10:53 am Eastern Time
Company Press Release
Theragenics Announces a 2-For-1 Stock Split
NORCROSS, Ga.--(BUSINESS WIRE)--March 16, 1998--Theragenics Corporation (NASDAQ:THRX - news), the Atlanta-based cancer treatment producer, today announced that its board of directors approved a 2-for-1 stock split, payable April 15 to shareholders of record March 31. After the split, Theragenics will have about 29.1 million shares outstanding.
Christine Jacobs, Theragenics' president and chief executive officer, said, ''Theragenics' stock price increased 91% during 1996, 59% during 1997 and 77% so far this year, based on consistently excellent performance by the Company. We decided to split our stock to improve its trading liquidity and to help ensure that it trades in a range that is accessible to a broad base of investors.''
Theragenics Corporation, based in Norcross, Ga., is the manufacturer of TheraSeed(R) a rice-sized device used in the treatment of localized prostate cancer with a one-time, minimally invasive procedure. For additional information on the Company, call Theragenics' Investor Relations Department at 800/998-8479. The Company's common stock is traded on the NASDAQ Stock Market under the symbol THRX.
--------------------------------------------------------------------------------
Contact:
Theragenics Corporation
Ron Warren
Director of Investor Relations
phone 800/998-THRX (8479) or 770/381-8338 |
